CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • CICON17 Day 2 Recap: Biomarkers, Novel Agents, and Adoptive Cell Therapies

    Day 2 of CICON17 offered a focused exploration of the latest discoveries and data from scientific studies…

    September 8, 2017| Arthur N. Brodsky, PhD
  • FDA Approves First-In-Class CAR T Cell Immunotherapy for Leukemia

    Children and young adults with relapsed/refractory acute lymphoblastic leukemia (ALL) can now receive the CD19-targeting CAR T…

    August 30, 2017| Arthur N. Brodsky, PhD
  • Highlights of the 2nd Annual Rational Combinations 360° Conference

    Biomarkers will be crucial to taking advantage of combination immunotherapy’s full potential

    August 11, 2017| Arthur N. Brodsky, PhD
  • AACR17 Update: CAR T Cells, Regulatory T Cells, and the Future of Immunotherapy

    Day two addressed several strategies to improve immunotherapy’s precision and effectiveness

    April 2, 2017| Arthur N. Brodsky, PhD
  • Cancer Immunotherapy Goes Viral

    A deadly virus that has killed more than 25 million people over the past 32 years has…

    June 24, 2013| Brian Brewer
Previous Page
1 … 3 4 5

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute